These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 20304584

  • 1. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR.
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [Abstract] [Full Text] [Related]

  • 2. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
    Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.
    J Natl Cancer Inst; 2008 Jul 16; 100(14):996-1002. PubMed ID: 18612130
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST).
    Zacharski LR, Chow BK, Howes PS, Lavori PW, Shamayeva G.
    Am Heart J; 2004 Sep 16; 148(3):386-92. PubMed ID: 15389223
    [Abstract] [Full Text] [Related]

  • 5. Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.
    Zacharski LR, Shamayeva G, Chow BK.
    Am Heart J; 2011 Nov 16; 162(5):949-957.e1. PubMed ID: 22093213
    [Abstract] [Full Text] [Related]

  • 6. Statins and biomarkers in claudicants with peripheral arterial disease: cross-sectional study.
    DePalma RG, Hayes VW, May PE, Cafferata HT, Mohammadpour HA, Brigg LA, Chow BK, Shamayeva G, Zacharski LR.
    Vascular; 2006 Nov 16; 14(4):193-200. PubMed ID: 17026909
    [Abstract] [Full Text] [Related]

  • 7. Cytokine signatures in atherosclerotic claudicants.
    DePalma RG, Hayes VW, Cafferata HT, Mohammadpour HA, Chow BK, Zacharski LR, Hall MR.
    J Surg Res; 2003 May 15; 111(2):215-21. PubMed ID: 12850465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
    Beckman JA, Preis O, Ridker PM, Gerhard-Herman M.
    Am J Cardiol; 2005 Nov 15; 96(10):1374-8. PubMed ID: 16275181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inflammation and anaemia in a broad spectrum of patients with heart failure.
    Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, van Veldhuisen DJ, van der Meer P.
    Heart; 2012 Aug 15; 98(16):1237-41. PubMed ID: 22730482
    [Abstract] [Full Text] [Related]

  • 16. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan 15; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 17. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K, Berger PB, Marso S, van Lente F, Brennan DM, Charnigo R, Topol EJ, Steinhubl S.
    Circ Cardiovasc Interv; 2009 Dec 15; 2(6):503-12. PubMed ID: 20031767
    [Abstract] [Full Text] [Related]

  • 18. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D.
    Ren Fail; 2007 Dec 15; 29(3):321-9. PubMed ID: 17497447
    [Abstract] [Full Text] [Related]

  • 19. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
    McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamenský G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J, CORONA Study Group.
    Circulation; 2009 Dec 01; 120(22):2188-96. PubMed ID: 19917888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.